TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11419884

Group type: EXPERIMENTAL
Intervention: Aspirin 81 mg daily
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Aspirin 325 mg every third day
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Aspirin 81 mg every third day
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Aspirin 40 mg every third day
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 9642312

Group type: EXPERIMENTAL
Intervention: Antipsychotic drugs
Number of subjects: 957

Group type: EXPERIMENTAL
Intervention: Concurrent use of multiple antipsychotic agents
Number of subjects: 957

Group type: EXPERIMENTAL
Intervention: Divided daily doses of antipsychotics
Number of subjects: 957

Group type: EXPERIMENTAL
Intervention: Co-administration of antipsychotic and antiparkinson drugs
Number of subjects: 957

Group type: EXPERIMENTAL
Intervention: Prescription patterns between acute and chronic patients
Number of subjects: 957
Study: 8329267

Group type: EXPERIMENTAL
Intervention: Single twitch stimulation at 0.1 Hz
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Train-of-four (TOF) stimulation at 2 Hz
Number of subjects: 0
Study: 3539708

Group type: EXPERIMENTAL
Intervention: Ranitidine therapy (150 mg bd)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo tablet
Number of subjects: 40
Study: 30463324

Group type: EXPERIMENTAL
Intervention: 500 mg/d Sensoril® (S500)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 38
Study: 27676151

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise (HIIE)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Continuous Exercise (CE)
Number of subjects: 14
Study: 24246116

Group type: EXPERIMENTAL
Intervention: Lurasidone monotherapy (20-60mg/d)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lurasidone monotherapy (80-120mg/d)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lurasidone adjunctive therapy (20-120mg/d)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lurasidone monotherapy and adjunctive therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22314520

Group type: EXPERIMENTAL
Intervention: Electronic conductivity device (ECD)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Normal pedicle finder (NPF)
Number of subjects: 42
Study: 20569447

Group type: EXPERIMENTAL
Intervention: Methylphenidate (0.5 mg/kg/day)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 157
Study: 17709207

Group type: EXPERIMENTAL
Intervention: Tramadol (75 mg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Acetaminophen (650 mg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Combination of acetaminophen (325 mg) and tramadol (37.5 mg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Saline (0.9%)
Number of subjects: 17
Study: 12375302

Group type: EXPERIMENTAL
Intervention: Vaccine intervention
Number of subjects: 0
Study: 9438767

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (1 mg/kg of body weight per hour; maximum, 1800 mg/d)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo (saline infusion)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Pentoxifylline
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 8586774

Group type: EXPERIMENTAL
Intervention: Psyllium-enriched Step I diet (3.2 g of soluble fiber per 1-oz box of cereal, 2 boxes per day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Step I control diet (less than 0.5 g of soluble fiber per 1-oz box of cereal, 2 boxes per day)
Number of subjects: 50
Study: 2770272

Group type: COMPARATOR
Intervention: Stationary cycle (C)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Rower (R)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Ski simulator (S)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Treadmill (walking) (T)
Number of subjects: 5
Study: 790146

Group type: EXPERIMENTAL
Intervention: Intensive consolidation therapy in a protected environment unit with antibiotic prophylaxis
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Intensive consolidation therapy in a protected environment unit without antibiotic prophylaxis
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Intensive consolidation therapy out of a protected environment unit with antibiotic prophylaxis
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Intensive consolidation therapy out of a protected environment unit without antibiotic prophylaxis
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Early consolidation therapy
Number of subjects: 13

Group type: COMPARATOR
Intervention: Conventional maintenance therapy
Number of subjects: 13
Study: 28323986

Group type: EXPERIMENTAL
Intervention: Chronic intranasal insulin treatment (40 IU, 4 times daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 25813656

Group type: EXPERIMENTAL
Intervention: Tadalafil 5 mg once daily (OaD)
Number of subjects: 423

Group type: COMPARATOR
Intervention: Tadalafil on-demand (PRN)
Number of subjects: 423

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 423
Study: 23404788

Group type: EXPERIMENTAL
Intervention: Taspoglutide 20 mg (10 mg for first 4 weeks)
Number of subjects: 305

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 305
Study: 21207158

Group type: EXPERIMENTAL
Intervention: Laparoscopic resection
Number of subjects: 40

Group type: COMPARATOR
Intervention: Open resection
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both laparoscopic and open resection
Number of subjects: 40
Study: 20443395

Group type: EXPERIMENTAL
Intervention: Videophone communication (Skype) for 30 minutes once a week for 12 weeks
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group (no videophone communication)
Number of subjects: 13
Study: 16979854

Group type: EXPERIMENTAL
Intervention: Sensory‐motor‐oral stimulation and non‐nutritive sucking
Number of subjects: 98

Group type: COMPARATOR
Intervention: Sham stimulation program
Number of subjects: 98
Study: 14757395

Group type: EXPERIMENTAL
Intervention: Health care assistants providing additional feeding support
Number of subjects: 592

Group type: COMPARATOR
Intervention: Control group (standard care without additional feeding support)
Number of subjects: 592
Study: 11699736

Group type: EXPERIMENTAL
Intervention: Braun Oral-B children's power toothbrush (D10)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 70
Study: 9446408

Group type: EXPERIMENTAL
Intervention: p21ras protein accumulation in tumors
Number of subjects: 80

Group type: COMPARATOR
Intervention: p21ras protein accumulation
Number of subjects: 80
Study: 8199828

Group type: EXPERIMENTAL
Intervention: Intravesical instillations with immuno‐ or chemotherapy
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: Location of tumour in high risk regions (prostatic urethra, bladder neck, posterior wall, trigone area)
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: Tumour multiplicity
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: Tumour stage
Number of subjects: 387

Group type: COMPARATOR
Intervention: Gender, age, history of recurrent disease, size of the largest tumour, tumour stage or grade
Number of subjects: 387
Study: 3592311

Group type: EXPERIMENTAL
Intervention: Mixed grass extract
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Highly purified timothy pollen
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Tyrosine‐bound mixture
Number of subjects: 60
Study: 31387606

Group type: EXPERIMENTAL
Intervention: Verubecestat 12 mg
Number of subjects: 1957

Group type: EXPERIMENTAL
Intervention: Verubecestat 40 mg
Number of subjects: 1957

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1957
Study: 28784336

Group type: EXPERIMENTAL
Intervention: 2 mg oestrogen daily (low-dose group)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: 6 mg oestrogen daily (high-dose group)
Number of subjects: 121
Study: 25305042

Group type: EXPERIMENTAL
Intervention: CRVO
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: BRVO
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control
Number of subjects: 36
Study: 23064871

Group type: EXPERIMENTAL
Intervention: Low-intensity eccentric contractions (10 %ECC)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Maximal eccentric contractions (MaxECC)
Number of subjects: 26
Study: 21229331

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT) with a threshold device (40% of maximum inspiratory pressure, MIP) for 30 min/day from the 2nd to the 30th postoperative day
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 30
Study: 19121500

Group type: EXPERIMENTAL
Intervention: Gingivally offset mandibular premolar brackets
Number of subjects: 83

Group type: COMPARATOR
Intervention: Standard mandibular premolar brackets
Number of subjects: 83
Study: 16477259

Group type: EXPERIMENTAL
Intervention: High-sensitivity C-reactive protein (hs-CRP) levels across quintiles
Number of subjects: 4231
Study: 15140632

Group type: EXPERIMENTAL
Intervention: Isradipine (0-10 mg/70 kg, p.o.)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Dextromethorphan (0-60 mg/70 kg, p.o.)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Isradipine combined with naloxone
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Dextromethorphan combined with naloxone
Number of subjects: 7

Group type: COMPARATOR
Intervention: Naloxone (0.15 mg/70 kg, i.m.)
Number of subjects: 7
Study: 12017799

Group type: EXPERIMENTAL
Intervention: Potassium nitrate (KNO3) combined with dimethyl isosorbide (DMI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Potassium nitrate (KNO3) alone
Number of subjects: 0
Study: 9868127

Group type: EXPERIMENTAL
Intervention: Mitomycin C
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control
Number of subjects: 44
Study: 8194687

Group type: EXPERIMENTAL
Intervention: Cyclosporine enemas (350 mg nightly for 4 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo enemas
Number of subjects: 40
Study: 3037899

Group type: EXPERIMENTAL
Intervention: Norfloxacin
Number of subjects: 206

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 206

Group type: COMPARATOR
Intervention: Vancomycin‐polymyxin
Number of subjects: 206

Group type: COMPARATOR
Intervention: TMP/SMX
Number of subjects: 206

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 206
Study: 31302767

Group type: EXPERIMENTAL
Intervention: Oral cryotherapy during the whole course of cytotoxic agents administration (arm A)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Oral cryotherapy during the second half of the course of cytotoxic agents administration (arm B)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Regular oral cryotherapy twice a day (arm C)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Conventional oral care without cryotherapy (arm D)
Number of subjects: 145
Study: 29733492

Group type: EXPERIMENTAL
Intervention: Motor Imagery (MI) training
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard training
Number of subjects: 62
Study: 30645838

Group type: EXPERIMENTAL
Intervention: Bushen Quyu Recipe (BQR) combined with acupuncture
Number of subjects: 170

Group type: COMPARATOR
Intervention: Cold needle puncture drainage operation alone (Control)
Number of subjects: 170
Study: 23860288

Group type: EXPERIMENTAL
Intervention: Carbohydrate supplementation (0.5 g·kg·h)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 12
Study: 24032187

Group type: EXPERIMENTAL
Intervention: Acupuncture prescription of regulating yin-yang and five viscera
Number of subjects: 700

Group type: COMPARATOR
Intervention: Acupuncture prescription of tranquilizing mind
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 700
Study: 20942276

Group type: EXPERIMENTAL
Intervention: Catgut implantation at Hanyan (GB 4), Baihui (GV 20), Shenmen (HT 7), Fenglong (ST 40), Taichong (LR 3), once every two weeks, for a total of 4 times.
Number of subjects: 94

Group type: COMPARATOR
Intervention: Deanxit, oral administration for eight weeks.
Number of subjects: 94
Study: 18769066

Group type: EXPERIMENTAL
Intervention: ORS + 25 g PHGG
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: ORS + 50 g PHGG
Number of subjects: 195

Group type: COMPARATOR
Intervention: ORS alone (control)
Number of subjects: 195
Study: 16948480

Group type: EXPERIMENTAL
Intervention: Whey protein (1.2 g/kg body mass whey protein + 0.3 g/kg body mass sucrose powder, N = 9: 6 female, 3 male)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Soy protein (1.2 g/kg body mass soy protein + 0.3 g/kg body mass sucrose powder, N = 9: 6 female, 3 male)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo (1.2 g/kg body mass maltodextrin + 0.3 g/kg body mass sucrose powder, N = 9: 6 female, 3 male)
Number of subjects: 27
Study: 14514574

Group type: EXPERIMENTAL
Intervention: Vitamin C (2 g/day) for 4 weeks
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control (no antioxidant)
Number of subjects: 39
Study: 10880891

Group type: EXPERIMENTAL
Intervention: 200 mg micronised fenofibrate
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: 267 mg micronised fenofibrate
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: 340 mg micronised fenofibrate
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: 400 mg micronised fenofibrate
Number of subjects: 340

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 340
Study: 8769284

Group type: EXPERIMENTAL
Intervention: Colloidal bismuth subcitrate (CBS) 120 mg four times a day for four weeks combined with metronidazole 250 mg four times a day for one week (group A, N = 21)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Matching placebo (group B, N = 20)
Number of subjects: 41
Study: 1570227

Group type: EXPERIMENTAL
Intervention: Controlled-release morphine 30-mg tablets (MSC) administered rectally
Number of subjects: 14

Group type: COMPARATOR
Intervention: Immediate-release morphine 30-mg suppositories (RMS)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Controlled-release morphine 30-mg tablets (MSC) administered orally
Number of subjects: 14
Study: 6399444

Group type: EXPERIMENTAL
Intervention: Four drugs commonly used for pain relief (specific drugs not mentioned)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Cost and safety considerations
Number of subjects: 1000
Study: 30820733

Group type: EXPERIMENTAL
Intervention: Number of fractures
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Severity of fractures
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Location of fractures
Number of subjects: 158
Study: 29177589

Group type: EXPERIMENTAL
Intervention: Core needle biopsy under ultrasound guidance prior to RFVTA
Number of subjects: 24

Group type: COMPARATOR
Intervention: Laparoscopic radiofrequency volumetric thermal ablation (RFVTA)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Laparoscopic myomectomy
Number of subjects: 24
Study: 26891840

Group type: EXPERIMENTAL
Intervention: PrEP for the general population
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: PrEP for gay men
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: PrEP for Black gay men
Number of subjects: 154

Group type: COMPARATOR
Intervention: Prejudice levels
Number of subjects: 154
Study: 24015787

Group type: EXPERIMENTAL
Intervention: Rapid Weight‐Loss trial (induced 2% dehydration)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control trial (euhydration maintained)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Both trials
Number of subjects: 8
Study: 23012344

Group type: EXPERIMENTAL
Intervention: Yoga intervention (one 50 min Dru Yoga session each week for 8 weeks and a 20 min DVD for home practice)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 74
Study: 20382637

Group type: EXPERIMENTAL
Intervention: Toremifene
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 243
Study: 17429632

Group type: EXPERIMENTAL
Intervention: Continuous 6-hour infusion of l-HOP (oxaliplatin)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Conventional 2-hour infusion of l-HOP (oxaliplatin)
Number of subjects: 64
Study: 16125590

Group type: EXPERIMENTAL
Intervention: T-cell depleted marrow and cyclosporine A (TCD arm; n=201)
Number of subjects: 405

Group type: COMPARATOR
Intervention: Methotrexate and cyclosporine A after transplantation of T-replete marrow (M/C arm; n=204)
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: T-cell depleted marrow and cyclosporine A (TCD arm)
Number of subjects: 405
Study: 14522768

Group type: EXPERIMENTAL
Intervention: Corneal ACR6D
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: AMO SI40NB
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Hydroview H60M
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: AcrySof MA60BM
Number of subjects: 88
Study: 10822287

Group type: EXPERIMENTAL
Intervention: Cranberry juice
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Blueberry juice
Number of subjects: 9

Group type: COMPARATOR
Intervention: Sucrose solution (control)
Number of subjects: 9
Study: 8860096

Group type: EXPERIMENTAL
Intervention: Insulin sensitivity index (S(I))
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Ambulatory blood pressure
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: A(2) allele of glycogen synthase
Number of subjects: 64
Study: 1513926

Group type: EXPERIMENTAL
Intervention: 15 percent nitrous oxide in oxygen
Number of subjects: 30

Group type: COMPARATOR
Intervention: 100 percent oxygen
Number of subjects: 30
Study: 6376229

Group type: EXPERIMENTAL
Intervention: Cimetidine 1 g, trimipramine 50 mg, prostaglandin E1 analogue 800 or 200 micrograms, low-dose antacid or placebo (antiulcer treatment)
Number of subjects: 197
Study: 31127611

Group type: EXPERIMENTAL
Intervention: Metal trabecular bone reconstruction system
Number of subjects: 66

Group type: COMPARATOR
Intervention: Free vascularized fibular graft
Number of subjects: 66
Study: 28270285

Group type: EXPERIMENTAL
Intervention: Automated tube potential selection technique with a preferred image quality of 288 mA/100 kV (Group 1)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Tube voltage of 100 kV with automated tube current modulation using a reference tube current of 288 mA (Group 2)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Both groups (Group 1 and Group 2)
Number of subjects: 59
Study: 26810483

Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch 130/0.42 (HES)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Ringer acetate
Number of subjects: 208
Study: 25060950

Group type: EXPERIMENTAL
Intervention: B0.25 group (3.75mg hyperbaric bupivacaine 2.5mg/ml)
Number of subjects: 66

Group type: COMPARATOR
Intervention: B0.5 group (7.5mg hyperbaric bupivacaine 5mg/ml)
Number of subjects: 66
Study: 22659390

Group type: EXPERIMENTAL
Intervention: SmokingZine website access for 1 hour per day during camp
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (no access to the website)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: SmokingZine website access
Number of subjects: 52
Study: 21058572

Group type: EXPERIMENTAL
Intervention: Higher identifiers primed with an out-group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Higher identifiers primed with the in-group
Number of subjects: 0
Study: 17414592

Group type: EXPERIMENTAL
Intervention: Ciprofibrate 100 mg daily for 8 weeks
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control (AHA Step II diet and physical activity)
Number of subjects: 75
Study: 15780695

Group type: EXPERIMENTAL
Intervention: Divalproex (valproate, Depakote)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 11369834

Group type: EXPERIMENTAL
Intervention: Treatment of established severe anaemia in patients with ESRD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intervention in haemodynamic risk factors (anaemia and hypertension)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Late intervention to normalize haemoglobin
Number of subjects: 0
Study: 10214563

Group type: EXPERIMENTAL
Intervention: Drug X
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 7824584

Group type: EXPERIMENTAL
Intervention: Breathing bear (BrBr)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Non-breathing bear (N-BrBr)
Number of subjects: 36
Study: 3578724

Group type: EXPERIMENTAL
Intervention: Spontaneous ventilation using nitrous oxide with halothane (group 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spontaneous ventilation using isoflurane (group 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Controlled ventilation with atracurium (group 3)
Number of subjects: 0
Study: 30212281

Group type: EXPERIMENTAL
Intervention: Lottery incentive intervention
Number of subjects: 100
Study: 26968272

Group type: EXPERIMENTAL
Intervention: Bupivacaine infiltration (20ml of 0.25% plain)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no bupivacaine infiltration)
Number of subjects: 80
Study: 23812594

Group type: EXPERIMENTAL
Intervention: Statin therapy for 8 months
Number of subjects: 119
Study: 22506497

Group type: EXPERIMENTAL
Intervention: Local sequential context provided by preceding facial expressions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preceding facial expressions
Number of subjects: 0
Study: 22032056

Group type: EXPERIMENTAL
Intervention: Externally irrigated-tip catheter (n = 25; 45 degrees C/40 W outside the coronary sinus and 45 degrees C/30 W inside the coronary sinus)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional-tip catheter (n = 25; 60 degrees C/60 W outside and 55 degrees C/35 W inside the coronary sinus)
Number of subjects: 50
Study: 18070186

Group type: EXPERIMENTAL
Intervention: Parenteral polyoestradiol phosphate (PEP) therapy (240 mg/month)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Orchidectomy
Number of subjects: 234
Study: 17071428

Group type: EXPERIMENTAL
Intervention: Amniotomy
Number of subjects: 128

Group type: COMPARATOR
Intervention: No amniotomy (Control)
Number of subjects: 128
Study: 12947426

Group type: EXPERIMENTAL
Intervention: Dietary intervention (reductions in total fat and refined carbohydrates, increased n‐3 over n‐6 plus saturated fatty acids, increased intake of dietary fibre and phytooestrogens)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 99
Study: 10868707

Group type: EXPERIMENTAL
Intervention: Short-interval group (14-35 days between tests)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Long-interval group (40-180 days between tests)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: All subjects
Number of subjects: 53